Skip to main content
. 2014 Aug 12;2014:161794. doi: 10.1155/2014/161794

Table 1.

Indications addressed by gene therapy clinical trials up to January 2014.

Ranking Indication Number of trials (n) Percentage with respect to total gene therapy clinical trials (%)
1 Cancer diseases 1274 63.8
2 Monogenic diseases 178 8.9
3 Infectious diseases 164 8.2
4 Cardiovascular diseases 162 8.1
5 Healthy volunteers 52 2.6
6 Gene marking 50 2.5
7 Neurological diseases 37 1.9
8 Other diseases 35 1.8
9 Ocular diseases 31 1.6
10 Inflammatory diseases 13 0.7